Tekla Capital Management’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-25,068
| Closed | -$4.14M | – | 205 |
|
|
2021
Q2 | $4.14M | Sell |
25,068
-78,875
| -76% | -$13.2M | 0.13% | 127 |
|
|
2021
Q1 | $15.9M | Sell |
103,943
-71,895
| -41% | -$9.76M | 0.55% | 49 |
|
|
2020
Q4 | $22.1M | Buy |
175,838
+96,312
| +121% | +$10.8M | 0.78% | 39 |
|
|
2020
Q3 | $8.07M | Sell |
79,526
-63,982
| -45% | -$6.52M | 0.3% | 76 |
|
|
2020
Q2 | $14M | Hold |
143,508
| – | – | 0.53% | 43 |
|
|
2020
Q1 | $11.9M | Sell |
143,508
-9,495
| -6% | -$926K | 0.54% | 41 |
|
|
2019
Q4 | $17M | Hold |
153,003
| – | – | 0.64% | 36 |
|
|
2019
Q3 | $15.2M | Hold |
153,003
| – | – | 0.66% | 35 |
|
|
2019
Q2 | $15.2M | Buy |
153,003
+9,466
| +7% | +$903K | 0.62% | 37 |
|
|
2019
Q1 | $15.8M | Buy |
143,537
+73,077
| +104% | +$7.64M | 0.64% | 37 |
|
|
2018
Q4 | $6.48M | Buy |
70,460
+38,000
| +117% | +$3.84M | 0.28% | 73 |
|
|
2018
Q3 | $3.58M | Hold |
32,460
| – | – | 0.13% | 113 |
|
|
2018
Q2 | $3.03M | Hold |
32,460
| – | – | 0.12% | 116 |
|
|
2018
Q1 | $2.69M | Sell |
32,460
-32,460
| -50% | -$2.88M | 0.1% | 122 |
|
|
2017
Q4 | $5.91M | Sell |
64,920
-37,080
| -36% | -$3.08M | 0.23% | 80 |
|
|
2017
Q3 | $7.77M | Hold |
102,000
| – | – | 0.28% | 68 |
|
|
2017
Q2 | $7.65M | Hold |
102,000
| – | – | 0.28% | 67 |
|
|
2017
Q1 | $6.65M | Hold |
102,000
| – | – | 0.26% | 71 |
|
|
2016
Q4 | $5.62M | Hold |
102,000
| – | – | 0.24% | 73 |
|
|
2016
Q3 | $5.76M | Hold |
102,000
| – | – | 0.22% | 79 |
|
|
2016
Q2 | $4.26M | Buy |
+102,000
| New | +$4.7M | 0.17% | 98 |
|
Other funds holding PRAH
Tekla Capital Management's PRAH Position: Q3 2021 in Review
Tekla Capital Management sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 25,068 shares — an estimated $4.14M sold.
Tekla Capital Management first reported a position in PRAH in Q2 2016 and held it in 21 quarters. The position peaked at $22.1M in Q4 2020. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Tekla Capital Management reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Tekla Capital Management sold 25,068 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $4.14M.
- Tekla Capital Management first reported a position in PRA Health Sciences, Inc. in Q2 2016 and held it in 21 quarters.
- Tekla Capital Management's PRA Health Sciences, Inc. position peaked at $22.1M in Q4 2020.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Tekla Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.